Hepatitis A and B screening and vaccination rates among patients with chronic liver disease

Figures & data

Figure 1. Screening rates for immunity.

Table 1. Hepatitis A virus antibody testing according to presence/absence of each Chronic Liver Disease – 2008 (A) Hepatitis A (N=792)

Variable		Frequency (Percent)		P-value
		Hep A Tested	Hep A Not Tested Tested
Cirrhosis	Yes	168 (54.90%) 4mm6446546mn,n,(((54.55%)	138 (45.10%)	0.8
	No	272 (55.97%) (55.97%)	214 (44.03%)
Nash	Yes	108 (55.67%)	86 (44.33%)	1.0
	No	332 (55.52%)	266 (44.48%)
Alcoholic Liver Disease	Yes	65 (48.51%)	69 (51.49%)	0.07
	No	375 (56.99%)	283 (43.01%)
Hemochromatosis	Yes	9 (40.91%)	13 (59.09%)	0.2
	No	431 (55.97%)	339 (43.03%)
Autoimmune Liver Disease/PBC/AIH	Yes	24 (51.06%)	23 (48.94%)	0.5
	No	416 (55.84%) (mmjmj((((55.69%)	329 (44.16%)
Primary Sclerosing Cholangitis	Yes	2 (33.33%)	4 (66.67%)	0.3
	No	438 (55.73%)	348 (44.27%)
Cryptogenic Cirrhosis	Yes	6 (33.33%)	12 (66.67%)	0.05
	No	434 (56.07%)	340 (43.93%)
Other Liver Disease	Yes	11 (23.40%)	36 (76.60%)	<.0001
	No	429 (57.58%)	316 (42.42%)
Chronic Hepatitis B	Yes	29 (67.44%)	14 (32.56%)	0.1
	No	411 (54.87%)	338 (45.13%)
Hepatitis C	Yes	244 (63.71%)	139 (36.29%)	<.0001
	No	196 (47.92%)	213 (52.08%)

^a Two patients without indicating hepatitis A tested or not were excluded from the 794 subjects.

Patients with Hepatitis C are more likely to get tested for Hepatitis A than patients without Hepatitis C.

Table 2. Hepatitis B virus antibody testing according to presence/absence of each Chronic Liver Disease -2008 (A) Hepatitis B (N=792)

Variable		Frequency (Percent)		P-value
		Hep B Tested	Hep B Not Tested
Cirrhosis	Yes	164 (53.59%)	142 (46.41%)	0.2
	No	282 (58.02%)	204 (41.98%)
Nash	Yes	114 (58.76%)	80 (41.24%)	0.4
	No	332 (55.52%)	266 (44.48%)
Alcoholic Liver Disease	Yes	70 (52.24%)	64 (47.76%)	0.3
	No	376 (57.14%)	282 (42.86%)
Hemochromatosis	Yes	9 (40.91%)	13 (59.09%)	0.1
	No	437 (56.75%)	333 (43.25%)
Autoimmune Liver Disease/PBC/AIH	Yes	22 (46.81%)	25 (53.19%)	0.2
	No	424 (56.91%)	321 (43.09%)
Primary Sclerosing Cholangitis	Yes	2 (33.33%)	4 (66.67%)	0.3
	No	444 (56.49%)	342 (43.51%)
Cryptogenic Cirrhosis	Yes	7 (38.89%)	11 (61.11%)	0.1
	No	439 (56.72%)	335 (43.28%)
Other Liver Disease	Yes	13 (27.66%)	34 (72.34%)	<.0001
	No	433 (58.12%)	312 (41.88%)
Chronic Hepatitis B	Yes	23 (53.49%)	20 (46.51%)	0.7
	No	423 (56.48%)	326 (43.525)
Hepatitis C	Yes	244 (63.71%)	139 (36.29%)	<.0001
	No	202 (49.39%)	207 (50.61%)

^a Two patients without indicating hepatitis B tested or not were excluded from the 794 subjects.

Patients with Hepatitis C are more likely to get tested for Hepatitis B than patients without Hepatitis C.

Figure 2. Completion of vaccination series in 2005 and 2008 in CLD patients who were susceptible to HAV with a negative antibody.

Figure 3. Completion of vaccination series in 2005 and 2008 in CLD patients who were susceptible to HBV with a negative antibody.